,text,position,name,last,events,dateString,collapsed,checked
0,"<p>New funding applications are referred to one of Pharmac's Funding Application Advisors (FAAs), who'll review the application to ensure they have the relevant information to undertake a preliminary analysis.&nbsp; They may seek more information if required.</p>
<p><a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/new-funding-applications/</a></p>",0,Application Received,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Nov 2022', 'fs': 'Nov 2022', 'change': None}, 'Event_Description': {'s': 'Application received', 'fs': 'Application received', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtG92AJ'}, 'Id': 'a0POZ00000TbtG92AJ', 'Event_Date__c': '2022-11-15', 'Event_Description__c': 'Application received', 'Stage__c': 'Application Received', 'Formatted_Date__c': 'Nov 2022', 'Status_History__c': 'a132P000000EDOAQA4'}, 'change': None}]",Nov 2022,False,True
1,"<p>Pharmac is identifying and gathering information required to get clinical advice.  The <a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/"" rel=""nofollow"">Pharmacology and Therapeutics Advisory Committee (PTAC)</a>  meets quarterly. There are also around 20 expert <a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/"" rel=""nofollow"">Specialist Advisory Committees (SACs)</a>, previously expert Subcommittees, which provide clinical evaluations in specialist areas. Specialist Advisory Committees meet as required to discuss issues referred to them by PTAC or Pharmac.</p>
<p style=""height: 20px"">&nbsp;</p>
<p>In November 2021, we introduced separate terms of reference for the SACs to make clear that these committees have different, but complementary, roles, expertise and perspectives to PTAC.</p>
<p style=""height: 15px"">&nbsp;</p>
<p>PTAC and SACs may make recommendations to Pharmac that differ from each other when looking at the same evidence. Pharmac considers the recommendations provided by all our clinical advisory committees when assessing applications.</p>
<p style=""height: 20px"">&nbsp;</p>
<p><a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/pharmacology-and-therapeutics-advisory-committee-ptac/ptac-terms-of-reference-july-2021/"" rel=""nofollow"">PTAC</a>  and <a class=""external-link"" href=""https://pharmac.govt.nz/about/expert-advice/specialist-advisory-committees/specialist-advisory-committee-terms-of-reference//"" rel=""nofollow"">Specialist Advisory Committees</a> records of the meeting will be published on this website in accordance with the Terms of Reference.</p>",1,Seeking Clinical Advice,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Mar 2023', 'fs': 'Mar 2023', 'change': None}, 'Event_Description': {'s': 'Clinical advice required', 'fs': 'Clinical advice required', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGA2AZ'}, 'Id': 'a0POZ00000TbtGA2AZ', 'Event_Date__c': '2023-03-21', 'Event_Description__c': 'Clinical advice required', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Mar 2023', 'Status_History__c': 'a132P000000EDXwQAO'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Mar 2023', 'fs': 'Mar 2023', 'change': None}, 'Event_Description': {'s': 'Assigned to Pharmacology and Therapeutics Advisory Committee (PTAC) meeting to provide advice on Friday 19 May 2023', 'fs': 'Assigned to Pharmacology and Therapeutics Advisory Committee (PTAC) meeting to provide advice on Friday 19 May 2023', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGB2AZ'}, 'Id': 'a0POZ00000TbtGB2AZ', 'Event_Date__c': '2023-03-23', 'Event_Description__c': 'Assigned to Pharmacology and Therapeutics Advisory Committee (PTAC) meeting to provide advice on Friday 19 May 2023', 'Stage__c': 'Seeking Clinical Advice', 'Formatted_Date__c': 'Mar 2023', 'Status_History__c': 'a13OZ0000018liqYAA'}, 'change': None}, {'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': '<p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Advisory Committee <strong>recommended</strong> that silver diamine fluoride (SDF) be listed with a <strong>high</strong> priority.</p><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>In making this recommendation the Committee considered:</p><p class=""ql-indent-1"">1.2.1.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The high health need of individuals with mild to moderate dental caries where the current available therapies are not suitable.</p><p class=""ql-indent-1"">1.2.2.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The strong evidence demonstrating Māori, Pacific peoples and other populations already experiencing inequitable health outcomes are disproportionately affected by dental caries.</p><p class=""ql-indent-1"">1.2.3.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The evidence supporting the cost-effectiveness of SDF in treating dental caries.</p><p class=""ql-indent-1"">1.2.4.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The suitability of SDF to be utilised in a variety of non-dental settings and potential to increase the accessibility of dental caries prevention and treatment.</p>', 'fs': '<p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Advisory Committee <strong>recommended</strong> that silver diamine fluoride (SDF) be listed with a <strong>high</strong> priority.</p><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>In making this recommendation the Committee considered:</p><p class=""ql-indent-1"">1.2.1.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The high health need of individuals with mild to moderate dental caries where the current available therapies are not suitable.</p><p class=""ql-indent-1"">1.2.2.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The strong evidence demonstrating Māori, Pacific peoples and other populations already experiencing inequitable health outcomes are disproportionately affected by dental caries.</p><p class=""ql-indent-1"">1.2.3.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The evidence supporting the cost-effectiveness of SDF in treating dental caries.</p><p class=""ql-indent-1"">1.2.4.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The suitability of SDF to be utilised in a variety of non-dental settings and potential to increase the accessibility of dental caries prevention and treatment.</p>', 'change': None}, 'Published_Discussion': {'s': '<h2><em>Māori impact</em></h2><p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee discussed the impact of funding SDF for the management of dental caries on Māori health areas of focus and Māori health outcomes. The Committee noted that Māori are disproportionately represented in the lowest income brackets, and experience significant barriers to accessing appropriate dental facilities for treatment. Barriers include a lack of culturally appropriate engagement, institutional racism, inequities in opportunities to access education to improve oral health literacy, the geographical setting of clinics and the challenges associated with transportation, work and childcare commitments that need to be navigated to access care. All of these contribute to Māori experiencing differential and inequitable access to the determinants of good oral health (<a href=""https://pubmed.ncbi.nlm.nih.gov/17640284/"" target=""_blank"">Jamieson &amp; Koopu. J Paediatr Child Health. 2007;43:732-9</a>).</p><h2><em>Health need</em></h2><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that oral health is an integral element of overall health and wellbeing, enabling essential daily function eating, speaking, smiling, and socialising without discomfort pain or embarrassment. Poor oral health significantly impacts an individual’s quality of life.\xa0The Committee noted the following studies demonstrating the high health need of individuals with dental caries:</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://issuu.com/associationofsalariedmedicalspecialists/docs/asms220501-tooth_be_told"" target=""_blank"">Toi Mata Hauora ASMS. Tooth be told: The case for universal dental care in Aotearoa New Zealand. 2022</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/23635896/"" target=""_blank"">Antunes et al. Pediatr Dent. 2013;35:37-42</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/35916114/"" target=""_blank"">Ky et al. Aust Dent J. 2022; 67:302-13</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34172117/"" target=""_blank"">Randall et al. Pediatr Dent. 2021;43:223-29</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/32161849/"" target=""_blank"">Antunes et al. Eur Endod J. 2017;3:2-8</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/19491160/"" target=""_blank"">Casamassimo et al. J Am Dent Assoc.\xa02009;140:650-7</a>.</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/30473200/"" target=""_blank"">Ruff et al. J Am Dent Assoc. 2019;150:111-21</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.otago.ac.nz/wellington/otago019612.pdf"" target=""_blank"">Robson et al. Oranga Waha. 2011</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/37020331/"" target=""_blank"">Lee et al. Community Dent Oral Epidemiol. 2023;51:388-98</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/29419880/"" target=""_blank"">Shackleton et al. Community Dent Oral Epidemiol. 2018;46:288-96</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/30367654/"" target=""_blank"">Meija et al. BMC Oral Health. 2018;18:176</a></p><p><span style=""color: black;"">1.3.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that New Zealand’s publicly funded dental care is not universal. Children up to the age of 18 years-old can access dental-care without cost. Disabled adults, adults with medical conditions who have been referred to a hospital-based (or associated) dental service by a general or dental practitioner, and individuals with community services cards who require emergency dental care are able to access publicly funded dental care, however there can be associated costs with the care for adults. The Committee considered that as a result of this, the primary group of people who would benefit from funded silver diamine would be children.</p><p><span style=""color: black;"">1.4.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted there are several measures for management and prevention of dental caries. In addition to diet modification, fluoride is known to protect the teeth against dental caries and with consistent and thorough brushing with fluoride-containing toothpaste and sufficient fluoride exposure through fluoridation of the water helping limit tooth decay. The Committee noted there are significant inequities in access to such preventive measures, with approximately only 60% of New Zealanders (on a registered water supply) having access to fluoridated water supplies.</p><p><span style=""color: black;"">1.5.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that in the dental setting, application of topical fluoride varnish or fissure sealants can be used as a preventative measure and there are interventions that can address mild to moderate dental caries such as glass ionomer sealants. For more advanced caries, a metal crown can be placed, or the tooth can be drilled to remove the decayed tooth tissue and restored using composite, resin modified glass ionomer or glass ionomer, or ultimately require extraction/removal of the tooth. The Committee noted that invasive dentistry can require time, which is limited in the public system, and in the private system has significant costs associated with it. Operative procedures can also be uncomfortable and/or traumatising experiences that may lead to fear and avoidance of dental treatment for some individuals.</p><p><span style=""color: black;"">1.6.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee considered the health needs for family and whānau of people with dental caries to be unclear due to limited available evidence.</p><p><span style=""color: black;"">1.7.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that there is strong evidence that dental caries disproportionately affect Māori, Pacific peoples and other groups already experiencing health inequities relative to the wider New Zealand population. The Committee noted a recent Pharmac analysis of hospitalisation data for 2019/20 (<a href=""https://tewhatuora.shinyapps.io/hospitals-web-tool/"" target=""_blank"">Te Whatu Ora Publicly Funded Hospitalisations data</a>), which reported 7,117 discharges for dental caries in one year (ICD10 code K02). The data indicated 77% of caries hospitalisations were in children aged 0-9 years (n=5,492) and that the risk of hospitalisations for Māori and Pacific children (0-9 years old) was twice as high as the risk for non-Māori, non-Pacific children (0-9 years old).</p><p><span style=""color: black;"">1.8.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted the following publications that address the disproportionate impact and subsequent inequitable oral health outcomes, dental caries can have on Māori, Pacific peoples and other populations already experiencing inequitable health outcomes:</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.health.govt.nz/system/files/documents/publications/wai-2575-maori-health-trends-report-04mar2020.pdf"" target=""_blank"">WAI 2575 Māori health trends 2019 report</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://onlinelibrary.wiley.com/doi/epdf/10.1111/ipd.12686?saml_referrer"" target=""_blank"">Thornley et al. Int J Paed Dentistry. 2021;31:251-60</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://minhealthnz.shinyapps.io/nz-health-survey-2021-22-annual-data-explorer/_w_af4c3a77/#!/home"" target=""_blank"">Manatū Hauora New Zealand Health Survey 2021/22</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/24102463/"" target=""_blank"">Whyman et al. Community Dent Oral Epidemiol. 2014;42:234-44</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.nzda.org.nz/assets/files/Archives/NZDJ_Articles/2021/September_2021/Working_towards_Maori_oral_health_equity_-_Why_te_Tiriti_o_Waitangi_needs_to_underpin_the_oral_health_system_using_evidence_from_the_New_Zealand_Oral_Health_Survey.pdf"" target=""_blank"">Lacey et al. NZDJ. 2021;117:105-10</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.sciencedirect.com/science/article/pii/S0140673619311468?via%3Dihub"" target=""_blank"">Peres et al. Lancet. 2019;394:249-60</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.tandfonline.com/doi/abs/10.1080/03036758.2022.2061018?journalCode=tnzr20"" target=""_blank"">Ruiz et al. J. R. Soc. N.Z. 2022;52:265-82</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/17640284/"" target=""_blank"">Jamieson &amp; Koopu. J Paediatr Child Health. 2007;43:732-9</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/25000808/"" target=""_blank"">McKelvey et al. N Z Dent J. 2014;110:58-64</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.moh.govt.nz/notebook/nbbooks.nsf/0/4EE1404403E04F59CC256D390076DD8C/$file/Improving%20child%20oral%20health.pdf"" target=""_blank"">Public Health Advisory Committee. 2003</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.otago.ac.nz/wellington/otago019612.pdf"" target=""_blank"">Robson et al. Oranga Waha – Oral Health Research Priorities for Māori: low-income adults, kaumātua, and Māori with disabilities, special needs and chronic health conditions. 2011</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.health.govt.nz/nz-health-statistics/health-statistics-and-data-sets/oral-health-data-and-stats/age-5-and-year-8-oral-health-data-community-oral-health-service"" target=""_blank"">Manatū Hauora, Community Oral Health Service, 2021</a></p><p><span style=""color: black;"">1.9.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that management of dental caries is not directly related to the government health priorities, however the impact that oral disease has on the individual is significant, and preventing and treating dental caries encompasses the health priorities to improve child wellbeing, mental wellbeing, and health equity.</p><h2><em>Health benefit</em></h2><p><span style=""color: black;"">1.10.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that SDF is a clear liquid containing silver, ammonia and 38% (44800ppm) fluoride ions and that one drop of the preparation contains 11.6mg fluoride and is sufficient to treat six teeth with caries. The Committee noted that SDF preparations are currently not approved by Medsafe for use in New Zealand and noted correspondence from Medsafe that preparations containing fluoride concentrations greater than 5.5mg/ml will need to be registered as a prescription medicine.</p><p><span style=""color: black;"">1.11.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that SDF is applied topically to the tooth. It disrupts the bacterial biofilm, remineralises the previously demineralised inorganic tooth, promotes tooth desensitisation and prevents dentine degradation. The Committee noted that SDF would be used in the management of early and moderate carious lesions.</p><p><span style=""color: black;"">1.12.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted the following studies to determine the health benefit SDF provides in the management of dental caries and noted the strength of the evidence differed between different age groups. The Committee considered that the evidence for children and elderly adults was of moderate strength but that the evidence for adults was weak.</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/37020768/"" target=""_blank"">Jain et al. Int J Clin Pediatr Dent. 2023;16:1-8</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/28972954/"" target=""_blank"">Chibinski et al. Caries Res. 2017;51:527-41</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34272061/"" target=""_blank"">Yawary and Hegde, Int. Dent. J. 2022;72:322-30</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/36460236/"" target=""_blank"">Aly et al. J Dent. 2023;128:104379</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34743243/"" target=""_blank"">Ballikaya et al. Clin Oral Investig; 2022;26:2197-205</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/36404644/"" target=""_blank"">Ericson et al. Gerodontology. 2022;epub</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/28812312/"" target=""_blank"">Hendre et al. Gerodontology. 2017;34:411-19</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/35104291/"" target=""_blank"">Ruff et al. PLoS One. 2022;17:30261627</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/31279925/"" target=""_blank"">Vollu et al. J Dent. 2019;88:103165</a></p><p><span style=""color: black;"">1.13.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that funding of SDF would produce a health benefit to family, whānau and wider society, if the individual receiving treatment was able to access SDF application.\xa0</p><p><span style=""color: black;"">1.14.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that there is a shortage of dentists, dental specialists and limited dental resources, funding, and access to treatment when general anaesthesia is required. The Committee considered that the simplicity of SDF application to dental caries could limit the need for complex and specialised equipment as it could be applied in an oral health care service, primary care facility or community setting by non-dental community health care workers. The Committee noted there would need to be training and support provided by the health care system to ensure SDF could be utilised in the community.</p><p><span style=""color: black;"">1.15.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that it was unclear how SDF would be implemented into current dental practices and considered that SDF could replace some current dental treatments. The Committee considered that SDF could primarily be utilised as either preventative, bridging or definitive treatment, and that it was not clear from the application or the evidence available which of these uses was likely to be more common.</p><p><span style=""color: black;"">1.16.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that if SDF was used as preventative treatment, then this would not necessarily need to be administered by dentists but could also be done by nurses or hygienists. The Committee considered use of SDF as a preventative treatment would likely result in greater uptake among populations that experience difficulties accessing dental care, as this would not necessarily require that people travel to a dental clinic, in contrast to preventative measures such as fissure sealants. The Committee considered that the target population and the requested use should be clarified, to further understand its likely use.</p><p><span style=""color: black;"">1.17.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that the evidence suggested that outcomes were better when dentists administered SDF, than when dental hygienists were responsible for administration. The Committee considered that the evidence did however suggest that outcomes were superior for dental hygienist administration of SDF, compared to placebo.</p><h2><em>Suitability</em></h2><p><span style=""color: black;"">1.18.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that in paediatric and special care dentistry, there is often a need to slow or stop lesion progression and ‘buy time’, allowing individuals to develop cognitively and/or acclimatise to community-based dental treating facilities and become more able to cope with restorative treatment solutions performed without the need for sedation or anaesthesia. The Committee noted that SDF treatment can also allow time to engage parents/carers in preventive oral health education and behavioural change (particularly in relation to diet and oral hygiene), to help stop the disease progression.</p><p><span style=""color: black;"">1.19.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that the applicant reports that SDF can be applied in a non-dental setting, which the applicant reports may reduce stress and anxiety for the individual and their whānau or others who are supporting the individual. The wider potential settings for administration also benefited individuals who are unable to access a dental clinic, such as individuals who live rurally or for those who experience difficulties with physical mobility. The Committee considered that this may also help reduce other barriers to accessing community clinics for people without transport, or for those who may also need to navigate other factors (such as work, school, or childcare considerations) to attend this treatment setting.</p><p><span style=""color: black;"">1.20.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that treatment of caries with SDF results in a visible dark stain and this may have cosmetic-related concerns for some individuals and their whānau. The Committee noted that the staining can be partially mitigated by immediately applying potassium iodide after applying SDF. The Committee noted that it was unclear whether an additional potassium iodide step could be used in the non-dental setting, and that may lead to some populations who experience less access to dental infrastructure experiencing greater degrees of tooth staining.</p><h2><em>Cost and savings</em></h2><p><span style=""color: black;"">1.21.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that the evidence provided suggests that the staining associated with SDF is not associated with diminished health-related quality of life in children, but the Committee discussed the possibility that teeth staining may be associated with a potential risk of bullying and marginalisation of the children who receive treatment.</p><p><span style=""color: black;"">1.22.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that, based on some news reports on dental treatment in The Waikato, approximately 10% of children would have carious teeth capped. The Committee therefore considered that for a subset of individuals, the comparator would be dental capping.</p><h2><em>Summary for assessment</em></h2><p><span style=""color: black;"">1.23.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Advisory Committee considered that the table below summarises its interpretation of the most appropriate PICO (population, intervention, comparator, outcomes) information for silver diamine if it were funded for the treatment of dental caries. The Committee considered that there were a number of potential ways that silver diamine could be used in New Zealand, and that the most likely PICO would depend on whether there were changes made elsewhere in the health system to facilitate access to SDF. This PICO captures key clinical aspects of the proposal and may be used to frame any future economic assessment by Pharmac staff. This PICO is based on the Advisory Committee’s assessment at this time and may differ from that requested by the applicant. The PICO may change based on new information, additional clinical advice, or further analysis by Pharmac staff.\xa0</p><p><img src=""/apptracker/servlet/rtaImage?eid=a0POZ00000TbtGC&amp;feoid=00N2P000000YsIc&amp;refid=0EMOZ0000006GwX"" alt=""image.png""></img></p>', 'fs': '<h2><em>Māori impact</em></h2><p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee discussed the impact of funding SDF for the management of dental caries on Māori health areas of focus and Māori health outcomes. The Committee noted that Māori are disproportionately represented in the lowest income brackets, and experience significant barriers to accessing appropriate dental facilities for treatment. Barriers include a lack of culturally appropriate engagement, institutional racism, inequities in opportunities to access education to improve oral health literacy, the geographical setting of clinics and the challenges associated with transportation, work and childcare commitments that need to be navigated to access care. All of these contribute to Māori experiencing differential and inequitable access to the determinants of good oral health (<a href=""https://pubmed.ncbi.nlm.nih.gov/17640284/"" target=""_blank"">Jamieson &amp; Koopu. J Paediatr Child Health. 2007;43:732-9</a>).</p><h2><em>Health need</em></h2><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that oral health is an integral element of overall health and wellbeing, enabling essential daily function eating, speaking, smiling, and socialising without discomfort pain or embarrassment. Poor oral health significantly impacts an individual’s quality of life.\xa0The Committee noted the following studies demonstrating the high health need of individuals with dental caries:</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://issuu.com/associationofsalariedmedicalspecialists/docs/asms220501-tooth_be_told"" target=""_blank"">Toi Mata Hauora ASMS. Tooth be told: The case for universal dental care in Aotearoa New Zealand. 2022</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/23635896/"" target=""_blank"">Antunes et al. Pediatr Dent. 2013;35:37-42</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/35916114/"" target=""_blank"">Ky et al. Aust Dent J. 2022; 67:302-13</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34172117/"" target=""_blank"">Randall et al. Pediatr Dent. 2021;43:223-29</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/32161849/"" target=""_blank"">Antunes et al. Eur Endod J. 2017;3:2-8</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/19491160/"" target=""_blank"">Casamassimo et al. J Am Dent Assoc.\xa02009;140:650-7</a>.</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/30473200/"" target=""_blank"">Ruff et al. J Am Dent Assoc. 2019;150:111-21</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.otago.ac.nz/wellington/otago019612.pdf"" target=""_blank"">Robson et al. Oranga Waha. 2011</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/37020331/"" target=""_blank"">Lee et al. Community Dent Oral Epidemiol. 2023;51:388-98</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/29419880/"" target=""_blank"">Shackleton et al. Community Dent Oral Epidemiol. 2018;46:288-96</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/30367654/"" target=""_blank"">Meija et al. BMC Oral Health. 2018;18:176</a></p><p><span style=""color: black;"">1.3.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that New Zealand’s publicly funded dental care is not universal. Children up to the age of 18 years-old can access dental-care without cost. Disabled adults, adults with medical conditions who have been referred to a hospital-based (or associated) dental service by a general or dental practitioner, and individuals with community services cards who require emergency dental care are able to access publicly funded dental care, however there can be associated costs with the care for adults. The Committee considered that as a result of this, the primary group of people who would benefit from funded silver diamine would be children.</p><p><span style=""color: black;"">1.4.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted there are several measures for management and prevention of dental caries. In addition to diet modification, fluoride is known to protect the teeth against dental caries and with consistent and thorough brushing with fluoride-containing toothpaste and sufficient fluoride exposure through fluoridation of the water helping limit tooth decay. The Committee noted there are significant inequities in access to such preventive measures, with approximately only 60% of New Zealanders (on a registered water supply) having access to fluoridated water supplies.</p><p><span style=""color: black;"">1.5.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that in the dental setting, application of topical fluoride varnish or fissure sealants can be used as a preventative measure and there are interventions that can address mild to moderate dental caries such as glass ionomer sealants. For more advanced caries, a metal crown can be placed, or the tooth can be drilled to remove the decayed tooth tissue and restored using composite, resin modified glass ionomer or glass ionomer, or ultimately require extraction/removal of the tooth. The Committee noted that invasive dentistry can require time, which is limited in the public system, and in the private system has significant costs associated with it. Operative procedures can also be uncomfortable and/or traumatising experiences that may lead to fear and avoidance of dental treatment for some individuals.</p><p><span style=""color: black;"">1.6.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee considered the health needs for family and whānau of people with dental caries to be unclear due to limited available evidence.</p><p><span style=""color: black;"">1.7.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that there is strong evidence that dental caries disproportionately affect Māori, Pacific peoples and other groups already experiencing health inequities relative to the wider New Zealand population. The Committee noted a recent Pharmac analysis of hospitalisation data for 2019/20 (<a href=""https://tewhatuora.shinyapps.io/hospitals-web-tool/"" target=""_blank"">Te Whatu Ora Publicly Funded Hospitalisations data</a>), which reported 7,117 discharges for dental caries in one year (ICD10 code K02). The data indicated 77% of caries hospitalisations were in children aged 0-9 years (n=5,492) and that the risk of hospitalisations for Māori and Pacific children (0-9 years old) was twice as high as the risk for non-Māori, non-Pacific children (0-9 years old).</p><p><span style=""color: black;"">1.8.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted the following publications that address the disproportionate impact and subsequent inequitable oral health outcomes, dental caries can have on Māori, Pacific peoples and other populations already experiencing inequitable health outcomes:</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.health.govt.nz/system/files/documents/publications/wai-2575-maori-health-trends-report-04mar2020.pdf"" target=""_blank"">WAI 2575 Māori health trends 2019 report</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://onlinelibrary.wiley.com/doi/epdf/10.1111/ipd.12686?saml_referrer"" target=""_blank"">Thornley et al. Int J Paed Dentistry. 2021;31:251-60</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://minhealthnz.shinyapps.io/nz-health-survey-2021-22-annual-data-explorer/_w_af4c3a77/#!/home"" target=""_blank"">Manatū Hauora New Zealand Health Survey 2021/22</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/24102463/"" target=""_blank"">Whyman et al. Community Dent Oral Epidemiol. 2014;42:234-44</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.nzda.org.nz/assets/files/Archives/NZDJ_Articles/2021/September_2021/Working_towards_Maori_oral_health_equity_-_Why_te_Tiriti_o_Waitangi_needs_to_underpin_the_oral_health_system_using_evidence_from_the_New_Zealand_Oral_Health_Survey.pdf"" target=""_blank"">Lacey et al. NZDJ. 2021;117:105-10</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.sciencedirect.com/science/article/pii/S0140673619311468?via%3Dihub"" target=""_blank"">Peres et al. Lancet. 2019;394:249-60</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.tandfonline.com/doi/abs/10.1080/03036758.2022.2061018?journalCode=tnzr20"" target=""_blank"">Ruiz et al. J. R. Soc. N.Z. 2022;52:265-82</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/17640284/"" target=""_blank"">Jamieson &amp; Koopu. J Paediatr Child Health. 2007;43:732-9</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/25000808/"" target=""_blank"">McKelvey et al. N Z Dent J. 2014;110:58-64</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.moh.govt.nz/notebook/nbbooks.nsf/0/4EE1404403E04F59CC256D390076DD8C/$file/Improving%20child%20oral%20health.pdf"" target=""_blank"">Public Health Advisory Committee. 2003</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.otago.ac.nz/wellington/otago019612.pdf"" target=""_blank"">Robson et al. Oranga Waha – Oral Health Research Priorities for Māori: low-income adults, kaumātua, and Māori with disabilities, special needs and chronic health conditions. 2011</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.health.govt.nz/nz-health-statistics/health-statistics-and-data-sets/oral-health-data-and-stats/age-5-and-year-8-oral-health-data-community-oral-health-service"" target=""_blank"">Manatū Hauora, Community Oral Health Service, 2021</a></p><p><span style=""color: black;"">1.9.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that management of dental caries is not directly related to the government health priorities, however the impact that oral disease has on the individual is significant, and preventing and treating dental caries encompasses the health priorities to improve child wellbeing, mental wellbeing, and health equity.</p><h2><em>Health benefit</em></h2><p><span style=""color: black;"">1.10.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that SDF is a clear liquid containing silver, ammonia and 38% (44800ppm) fluoride ions and that one drop of the preparation contains 11.6mg fluoride and is sufficient to treat six teeth with caries. The Committee noted that SDF preparations are currently not approved by Medsafe for use in New Zealand and noted correspondence from Medsafe that preparations containing fluoride concentrations greater than 5.5mg/ml will need to be registered as a prescription medicine.</p><p><span style=""color: black;"">1.11.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that SDF is applied topically to the tooth. It disrupts the bacterial biofilm, remineralises the previously demineralised inorganic tooth, promotes tooth desensitisation and prevents dentine degradation. The Committee noted that SDF would be used in the management of early and moderate carious lesions.</p><p><span style=""color: black;"">1.12.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted the following studies to determine the health benefit SDF provides in the management of dental caries and noted the strength of the evidence differed between different age groups. The Committee considered that the evidence for children and elderly adults was of moderate strength but that the evidence for adults was weak.</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/37020768/"" target=""_blank"">Jain et al. Int J Clin Pediatr Dent. 2023;16:1-8</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/28972954/"" target=""_blank"">Chibinski et al. Caries Res. 2017;51:527-41</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34272061/"" target=""_blank"">Yawary and Hegde, Int. Dent. J. 2022;72:322-30</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/36460236/"" target=""_blank"">Aly et al. J Dent. 2023;128:104379</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34743243/"" target=""_blank"">Ballikaya et al. Clin Oral Investig; 2022;26:2197-205</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/36404644/"" target=""_blank"">Ericson et al. Gerodontology. 2022;epub</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/28812312/"" target=""_blank"">Hendre et al. Gerodontology. 2017;34:411-19</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/35104291/"" target=""_blank"">Ruff et al. PLoS One. 2022;17:30261627</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/31279925/"" target=""_blank"">Vollu et al. J Dent. 2019;88:103165</a></p><p><span style=""color: black;"">1.13.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that funding of SDF would produce a health benefit to family, whānau and wider society, if the individual receiving treatment was able to access SDF application.\xa0</p><p><span style=""color: black;"">1.14.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that there is a shortage of dentists, dental specialists and limited dental resources, funding, and access to treatment when general anaesthesia is required. The Committee considered that the simplicity of SDF application to dental caries could limit the need for complex and specialised equipment as it could be applied in an oral health care service, primary care facility or community setting by non-dental community health care workers. The Committee noted there would need to be training and support provided by the health care system to ensure SDF could be utilised in the community.</p><p><span style=""color: black;"">1.15.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that it was unclear how SDF would be implemented into current dental practices and considered that SDF could replace some current dental treatments. The Committee considered that SDF could primarily be utilised as either preventative, bridging or definitive treatment, and that it was not clear from the application or the evidence available which of these uses was likely to be more common.</p><p><span style=""color: black;"">1.16.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that if SDF was used as preventative treatment, then this would not necessarily need to be administered by dentists but could also be done by nurses or hygienists. The Committee considered use of SDF as a preventative treatment would likely result in greater uptake among populations that experience difficulties accessing dental care, as this would not necessarily require that people travel to a dental clinic, in contrast to preventative measures such as fissure sealants. The Committee considered that the target population and the requested use should be clarified, to further understand its likely use.</p><p><span style=""color: black;"">1.17.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that the evidence suggested that outcomes were better when dentists administered SDF, than when dental hygienists were responsible for administration. The Committee considered that the evidence did however suggest that outcomes were superior for dental hygienist administration of SDF, compared to placebo.</p><h2><em>Suitability</em></h2><p><span style=""color: black;"">1.18.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that in paediatric and special care dentistry, there is often a need to slow or stop lesion progression and ‘buy time’, allowing individuals to develop cognitively and/or acclimatise to community-based dental treating facilities and become more able to cope with restorative treatment solutions performed without the need for sedation or anaesthesia. The Committee noted that SDF treatment can also allow time to engage parents/carers in preventive oral health education and behavioural change (particularly in relation to diet and oral hygiene), to help stop the disease progression.</p><p><span style=""color: black;"">1.19.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that the applicant reports that SDF can be applied in a non-dental setting, which the applicant reports may reduce stress and anxiety for the individual and their whānau or others who are supporting the individual. The wider potential settings for administration also benefited individuals who are unable to access a dental clinic, such as individuals who live rurally or for those who experience difficulties with physical mobility. The Committee considered that this may also help reduce other barriers to accessing community clinics for people without transport, or for those who may also need to navigate other factors (such as work, school, or childcare considerations) to attend this treatment setting.</p><p><span style=""color: black;"">1.20.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that treatment of caries with SDF results in a visible dark stain and this may have cosmetic-related concerns for some individuals and their whānau. The Committee noted that the staining can be partially mitigated by immediately applying potassium iodide after applying SDF. The Committee noted that it was unclear whether an additional potassium iodide step could be used in the non-dental setting, and that may lead to some populations who experience less access to dental infrastructure experiencing greater degrees of tooth staining.</p><h2><em>Cost and savings</em></h2><p><span style=""color: black;"">1.21.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that the evidence provided suggests that the staining associated with SDF is not associated with diminished health-related quality of life in children, but the Committee discussed the possibility that teeth staining may be associated with a potential risk of bullying and marginalisation of the children who receive treatment.</p><p><span style=""color: black;"">1.22.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that, based on some news reports on dental treatment in The Waikato, approximately 10% of children would have carious teeth capped. The Committee therefore considered that for a subset of individuals, the comparator would be dental capping.</p><h2><em>Summary for assessment</em></h2><p><span style=""color: black;"">1.23.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Advisory Committee considered that the table below summarises its interpretation of the most appropriate PICO (population, intervention, comparator, outcomes) information for silver diamine if it were funded for the treatment of dental caries. The Committee considered that there were a number of potential ways that silver diamine could be used in New Zealand, and that the most likely PICO would depend on whether there were changes made elsewhere in the health system to facilitate access to SDF. This PICO captures key clinical aspects of the proposal and may be used to frame any future economic assessment by Pharmac staff. This PICO is based on the Advisory Committee’s assessment at this time and may differ from that requested by the applicant. The PICO may change based on new information, additional clinical advice, or further analysis by Pharmac staff.\xa0</p><p><img src=""/apptracker/servlet/rtaImage?eid=a0POZ00000TbtGC&amp;feoid=00N2P000000YsIc&amp;refid=0EMOZ0000006GwX"" alt=""image.png""></img></p>', 'change': None}, 'Published_Application': {'s': '<p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee reviewed a clinician application for silver diamine fluoride (SDF) for the management of mild and moderate tooth caries.</p><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee took into account, where applicable, Pharmac’s relevant decision-making framework when considering this agenda item.\xa0</p>', 'fs': '<p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee reviewed a clinician application for silver diamine fluoride (SDF) for the management of mild and moderate tooth caries.</p><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee took into account, where applicable, Pharmac’s relevant decision-making framework when considering this agenda item.\xa0</p>', 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': 'High', 'fs': 'High', 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Aug 2023', 'fs': 'Aug 2023', 'change': None}, 'Event_Description': {'s': 'Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Friday 19 May 2023.', 'fs': 'Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Friday 19 May 2023.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGC2AZ'}, 'Id': 'a0POZ00000TbtGC2AZ', 'Event_Date__c': '2023-08-16', 'Event_Description__c': 'Clinical advice received from Pharmacology and Therapeutics Advisory Committee (PTAC) at meeting Friday 19 May 2023.', 'Stage__c': 'Seeking Clinical Advice', 'Outcome__c': 'High', 'Formatted_Date__c': 'Aug 2023', 'Published_Recommendation__c': '<p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Advisory Committee <strong>recommended</strong> that silver diamine fluoride (SDF) be listed with a <strong>high</strong> priority.</p><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>In making this recommendation the Committee considered:</p><p class=""ql-indent-1"">1.2.1.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The high health need of individuals with mild to moderate dental caries where the current available therapies are not suitable.</p><p class=""ql-indent-1"">1.2.2.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The strong evidence demonstrating Māori, Pacific peoples and other populations already experiencing inequitable health outcomes are disproportionately affected by dental caries.</p><p class=""ql-indent-1"">1.2.3.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The evidence supporting the cost-effectiveness of SDF in treating dental caries.</p><p class=""ql-indent-1"">1.2.4.<span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0</span>The suitability of SDF to be utilised in a variety of non-dental settings and potential to increase the accessibility of dental caries prevention and treatment.</p>', 'Published_Application__c': '<p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee reviewed a clinician application for silver diamine fluoride (SDF) for the management of mild and moderate tooth caries.</p><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee took into account, where applicable, Pharmac’s relevant decision-making framework when considering this agenda item.\xa0</p>', 'Published_Discussion__c': '<h2><em>Māori impact</em></h2><p><span style=""color: black;"">1.1.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee discussed the impact of funding SDF for the management of dental caries on Māori health areas of focus and Māori health outcomes. The Committee noted that Māori are disproportionately represented in the lowest income brackets, and experience significant barriers to accessing appropriate dental facilities for treatment. Barriers include a lack of culturally appropriate engagement, institutional racism, inequities in opportunities to access education to improve oral health literacy, the geographical setting of clinics and the challenges associated with transportation, work and childcare commitments that need to be navigated to access care. All of these contribute to Māori experiencing differential and inequitable access to the determinants of good oral health (<a href=""https://pubmed.ncbi.nlm.nih.gov/17640284/"" target=""_blank"">Jamieson &amp; Koopu. J Paediatr Child Health. 2007;43:732-9</a>).</p><h2><em>Health need</em></h2><p><span style=""color: black;"">1.2.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that oral health is an integral element of overall health and wellbeing, enabling essential daily function eating, speaking, smiling, and socialising without discomfort pain or embarrassment. Poor oral health significantly impacts an individual’s quality of life.\xa0The Committee noted the following studies demonstrating the high health need of individuals with dental caries:</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://issuu.com/associationofsalariedmedicalspecialists/docs/asms220501-tooth_be_told"" target=""_blank"">Toi Mata Hauora ASMS. Tooth be told: The case for universal dental care in Aotearoa New Zealand. 2022</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/23635896/"" target=""_blank"">Antunes et al. Pediatr Dent. 2013;35:37-42</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/35916114/"" target=""_blank"">Ky et al. Aust Dent J. 2022; 67:302-13</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34172117/"" target=""_blank"">Randall et al. Pediatr Dent. 2021;43:223-29</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/32161849/"" target=""_blank"">Antunes et al. Eur Endod J. 2017;3:2-8</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/19491160/"" target=""_blank"">Casamassimo et al. J Am Dent Assoc.\xa02009;140:650-7</a>.</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/30473200/"" target=""_blank"">Ruff et al. J Am Dent Assoc. 2019;150:111-21</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.otago.ac.nz/wellington/otago019612.pdf"" target=""_blank"">Robson et al. Oranga Waha. 2011</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/37020331/"" target=""_blank"">Lee et al. Community Dent Oral Epidemiol. 2023;51:388-98</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/29419880/"" target=""_blank"">Shackleton et al. Community Dent Oral Epidemiol. 2018;46:288-96</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/30367654/"" target=""_blank"">Meija et al. BMC Oral Health. 2018;18:176</a></p><p><span style=""color: black;"">1.3.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that New Zealand’s publicly funded dental care is not universal. Children up to the age of 18 years-old can access dental-care without cost. Disabled adults, adults with medical conditions who have been referred to a hospital-based (or associated) dental service by a general or dental practitioner, and individuals with community services cards who require emergency dental care are able to access publicly funded dental care, however there can be associated costs with the care for adults. The Committee considered that as a result of this, the primary group of people who would benefit from funded silver diamine would be children.</p><p><span style=""color: black;"">1.4.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted there are several measures for management and prevention of dental caries. In addition to diet modification, fluoride is known to protect the teeth against dental caries and with consistent and thorough brushing with fluoride-containing toothpaste and sufficient fluoride exposure through fluoridation of the water helping limit tooth decay. The Committee noted there are significant inequities in access to such preventive measures, with approximately only 60% of New Zealanders (on a registered water supply) having access to fluoridated water supplies.</p><p><span style=""color: black;"">1.5.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that in the dental setting, application of topical fluoride varnish or fissure sealants can be used as a preventative measure and there are interventions that can address mild to moderate dental caries such as glass ionomer sealants. For more advanced caries, a metal crown can be placed, or the tooth can be drilled to remove the decayed tooth tissue and restored using composite, resin modified glass ionomer or glass ionomer, or ultimately require extraction/removal of the tooth. The Committee noted that invasive dentistry can require time, which is limited in the public system, and in the private system has significant costs associated with it. Operative procedures can also be uncomfortable and/or traumatising experiences that may lead to fear and avoidance of dental treatment for some individuals.</p><p><span style=""color: black;"">1.6.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee considered the health needs for family and whānau of people with dental caries to be unclear due to limited available evidence.</p><p><span style=""color: black;"">1.7.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that there is strong evidence that dental caries disproportionately affect Māori, Pacific peoples and other groups already experiencing health inequities relative to the wider New Zealand population. The Committee noted a recent Pharmac analysis of hospitalisation data for 2019/20 (<a href=""https://tewhatuora.shinyapps.io/hospitals-web-tool/"" target=""_blank"">Te Whatu Ora Publicly Funded Hospitalisations data</a>), which reported 7,117 discharges for dental caries in one year (ICD10 code K02). The data indicated 77% of caries hospitalisations were in children aged 0-9 years (n=5,492) and that the risk of hospitalisations for Māori and Pacific children (0-9 years old) was twice as high as the risk for non-Māori, non-Pacific children (0-9 years old).</p><p><span style=""color: black;"">1.8.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted the following publications that address the disproportionate impact and subsequent inequitable oral health outcomes, dental caries can have on Māori, Pacific peoples and other populations already experiencing inequitable health outcomes:</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.health.govt.nz/system/files/documents/publications/wai-2575-maori-health-trends-report-04mar2020.pdf"" target=""_blank"">WAI 2575 Māori health trends 2019 report</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://onlinelibrary.wiley.com/doi/epdf/10.1111/ipd.12686?saml_referrer"" target=""_blank"">Thornley et al. Int J Paed Dentistry. 2021;31:251-60</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://minhealthnz.shinyapps.io/nz-health-survey-2021-22-annual-data-explorer/_w_af4c3a77/#!/home"" target=""_blank"">Manatū Hauora New Zealand Health Survey 2021/22</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/24102463/"" target=""_blank"">Whyman et al. Community Dent Oral Epidemiol. 2014;42:234-44</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.nzda.org.nz/assets/files/Archives/NZDJ_Articles/2021/September_2021/Working_towards_Maori_oral_health_equity_-_Why_te_Tiriti_o_Waitangi_needs_to_underpin_the_oral_health_system_using_evidence_from_the_New_Zealand_Oral_Health_Survey.pdf"" target=""_blank"">Lacey et al. NZDJ. 2021;117:105-10</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.sciencedirect.com/science/article/pii/S0140673619311468?via%3Dihub"" target=""_blank"">Peres et al. Lancet. 2019;394:249-60</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.tandfonline.com/doi/abs/10.1080/03036758.2022.2061018?journalCode=tnzr20"" target=""_blank"">Ruiz et al. J. R. Soc. N.Z. 2022;52:265-82</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/17640284/"" target=""_blank"">Jamieson &amp; Koopu. J Paediatr Child Health. 2007;43:732-9</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/25000808/"" target=""_blank"">McKelvey et al. N Z Dent J. 2014;110:58-64</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.moh.govt.nz/notebook/nbbooks.nsf/0/4EE1404403E04F59CC256D390076DD8C/$file/Improving%20child%20oral%20health.pdf"" target=""_blank"">Public Health Advisory Committee. 2003</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.otago.ac.nz/wellington/otago019612.pdf"" target=""_blank"">Robson et al. Oranga Waha – Oral Health Research Priorities for Māori: low-income adults, kaumātua, and Māori with disabilities, special needs and chronic health conditions. 2011</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://www.health.govt.nz/nz-health-statistics/health-statistics-and-data-sets/oral-health-data-and-stats/age-5-and-year-8-oral-health-data-community-oral-health-service"" target=""_blank"">Manatū Hauora, Community Oral Health Service, 2021</a></p><p><span style=""color: black;"">1.9.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span>The Committee noted that management of dental caries is not directly related to the government health priorities, however the impact that oral disease has on the individual is significant, and preventing and treating dental caries encompasses the health priorities to improve child wellbeing, mental wellbeing, and health equity.</p><h2><em>Health benefit</em></h2><p><span style=""color: black;"">1.10.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that SDF is a clear liquid containing silver, ammonia and 38% (44800ppm) fluoride ions and that one drop of the preparation contains 11.6mg fluoride and is sufficient to treat six teeth with caries. The Committee noted that SDF preparations are currently not approved by Medsafe for use in New Zealand and noted correspondence from Medsafe that preparations containing fluoride concentrations greater than 5.5mg/ml will need to be registered as a prescription medicine.</p><p><span style=""color: black;"">1.11.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that SDF is applied topically to the tooth. It disrupts the bacterial biofilm, remineralises the previously demineralised inorganic tooth, promotes tooth desensitisation and prevents dentine degradation. The Committee noted that SDF would be used in the management of early and moderate carious lesions.</p><p><span style=""color: black;"">1.12.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted the following studies to determine the health benefit SDF provides in the management of dental caries and noted the strength of the evidence differed between different age groups. The Committee considered that the evidence for children and elderly adults was of moderate strength but that the evidence for adults was weak.</p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/37020768/"" target=""_blank"">Jain et al. Int J Clin Pediatr Dent. 2023;16:1-8</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/28972954/"" target=""_blank"">Chibinski et al. Caries Res. 2017;51:527-41</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34272061/"" target=""_blank"">Yawary and Hegde, Int. Dent. J. 2022;72:322-30</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/36460236/"" target=""_blank"">Aly et al. J Dent. 2023;128:104379</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/34743243/"" target=""_blank"">Ballikaya et al. Clin Oral Investig; 2022;26:2197-205</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/36404644/"" target=""_blank"">Ericson et al. Gerodontology. 2022;epub</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/28812312/"" target=""_blank"">Hendre et al. Gerodontology. 2017;34:411-19</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/35104291/"" target=""_blank"">Ruff et al. PLoS One. 2022;17:30261627</a></p><p class=""ql-indent-1""><span style=""font-family: Symbol;"">·</span><span style=""font-size: 7pt;"">\xa0\xa0\xa0\xa0\xa0\xa0\xa0\xa0</span><a href=""https://pubmed.ncbi.nlm.nih.gov/31279925/"" target=""_blank"">Vollu et al. J Dent. 2019;88:103165</a></p><p><span style=""color: black;"">1.13.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that funding of SDF would produce a health benefit to family, whānau and wider society, if the individual receiving treatment was able to access SDF application.\xa0</p><p><span style=""color: black;"">1.14.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that there is a shortage of dentists, dental specialists and limited dental resources, funding, and access to treatment when general anaesthesia is required. The Committee considered that the simplicity of SDF application to dental caries could limit the need for complex and specialised equipment as it could be applied in an oral health care service, primary care facility or community setting by non-dental community health care workers. The Committee noted there would need to be training and support provided by the health care system to ensure SDF could be utilised in the community.</p><p><span style=""color: black;"">1.15.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that it was unclear how SDF would be implemented into current dental practices and considered that SDF could replace some current dental treatments. The Committee considered that SDF could primarily be utilised as either preventative, bridging or definitive treatment, and that it was not clear from the application or the evidence available which of these uses was likely to be more common.</p><p><span style=""color: black;"">1.16.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that if SDF was used as preventative treatment, then this would not necessarily need to be administered by dentists but could also be done by nurses or hygienists. The Committee considered use of SDF as a preventative treatment would likely result in greater uptake among populations that experience difficulties accessing dental care, as this would not necessarily require that people travel to a dental clinic, in contrast to preventative measures such as fissure sealants. The Committee considered that the target population and the requested use should be clarified, to further understand its likely use.</p><p><span style=""color: black;"">1.17.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that the evidence suggested that outcomes were better when dentists administered SDF, than when dental hygienists were responsible for administration. The Committee considered that the evidence did however suggest that outcomes were superior for dental hygienist administration of SDF, compared to placebo.</p><h2><em>Suitability</em></h2><p><span style=""color: black;"">1.18.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that in paediatric and special care dentistry, there is often a need to slow or stop lesion progression and ‘buy time’, allowing individuals to develop cognitively and/or acclimatise to community-based dental treating facilities and become more able to cope with restorative treatment solutions performed without the need for sedation or anaesthesia. The Committee noted that SDF treatment can also allow time to engage parents/carers in preventive oral health education and behavioural change (particularly in relation to diet and oral hygiene), to help stop the disease progression.</p><p><span style=""color: black;"">1.19.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that the applicant reports that SDF can be applied in a non-dental setting, which the applicant reports may reduce stress and anxiety for the individual and their whānau or others who are supporting the individual. The wider potential settings for administration also benefited individuals who are unable to access a dental clinic, such as individuals who live rurally or for those who experience difficulties with physical mobility. The Committee considered that this may also help reduce other barriers to accessing community clinics for people without transport, or for those who may also need to navigate other factors (such as work, school, or childcare considerations) to attend this treatment setting.</p><p><span style=""color: black;"">1.20.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee noted that treatment of caries with SDF results in a visible dark stain and this may have cosmetic-related concerns for some individuals and their whānau. The Committee noted that the staining can be partially mitigated by immediately applying potassium iodide after applying SDF. The Committee noted that it was unclear whether an additional potassium iodide step could be used in the non-dental setting, and that may lead to some populations who experience less access to dental infrastructure experiencing greater degrees of tooth staining.</p><h2><em>Cost and savings</em></h2><p><span style=""color: black;"">1.21.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that the evidence provided suggests that the staining associated with SDF is not associated with diminished health-related quality of life in children, but the Committee discussed the possibility that teeth staining may be associated with a potential risk of bullying and marginalisation of the children who receive treatment.</p><p><span style=""color: black;"">1.22.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Committee considered that, based on some news reports on dental treatment in The Waikato, approximately 10% of children would have carious teeth capped. The Committee therefore considered that for a subset of individuals, the comparator would be dental capping.</p><h2><em>Summary for assessment</em></h2><p><span style=""color: black;"">1.23.</span><span style=""color: black; font-size: 7pt;"">\xa0\xa0\xa0\xa0</span>The Advisory Committee considered that the table below summarises its interpretation of the most appropriate PICO (population, intervention, comparator, outcomes) information for silver diamine if it were funded for the treatment of dental caries. The Committee considered that there were a number of potential ways that silver diamine could be used in New Zealand, and that the most likely PICO would depend on whether there were changes made elsewhere in the health system to facilitate access to SDF. This PICO captures key clinical aspects of the proposal and may be used to frame any future economic assessment by Pharmac staff. This PICO is based on the Advisory Committee’s assessment at this time and may differ from that requested by the applicant. The PICO may change based on new information, additional clinical advice, or further analysis by Pharmac staff.\xa0</p><p><img src=""/apptracker/servlet/rtaImage?eid=a0POZ00000TbtGC&amp;feoid=00N2P000000YsIc&amp;refid=0EMOZ0000006GwX"" alt=""image.png""></img></p>', 'Status_History__c': 'a13OZ000001RU3GYAW'}, 'change': None}]",Mar 2023,False,True
2,"<p>Following Clinical Advice, Pharmac staff considers the advice and the funding application under goes an assessment using our&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/factors-for-consideration/"" rel=""nofollow"">Factors for Consideration</a>&nbsp;framework and seeks additional information as required.</p>
<p>&nbsp;</p>
<p>Research and Economic analysis are undertaken.&nbsp; This focuses on the costs and benefits of a proposed course of action. Economics is based on three fundamental concepts that summarise the issues Pharmac faces daily:&nbsp;</p>
<ul>
<li>Scarcity &ndash; resources will always be insufficient to support all possible activities.</li>
<li>Choices &ndash; due to scarce resources, decisions must be made about how best to use them.</li>
<li>Opportunity cost &ndash; by choosing to use resources one way, we forgo other opportunities to use the same resources.</li>
</ul>
<p>&nbsp;</p>
<p>For further information on the purpose of, and techniques for, undertaking economic analysis in health care, please refer&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/economic-analysis/</a></p>",2,Under Assessment,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Aug 2023', 'fs': 'Aug 2023', 'change': None}, 'Event_Description': {'s': 'Working to compare options', 'fs': 'Working to compare options', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGD2AZ'}, 'Id': 'a0POZ00000TbtGD2AZ', 'Event_Date__c': '2023-08-17', 'Event_Description__c': 'Working to compare options', 'Stage__c': 'Under Assessment', 'Formatted_Date__c': 'Aug 2023', 'Status_History__c': 'a13OZ000005k9AIYAY'}, 'change': None}]",Aug 2023,False,True
3,"<p>Pharmac staff uses a prioritisation process to compare and rank funding options. Possible opportunities for new investment will always exceed the budget Pharmac has available; therefore, prioritisation is an intrinsic part of Pharmac’s decision-making process.</p>
<p>The relative ranking of options aims to support Pharmac&rsquo;s statutory objective &ldquo;to secure for eligible people in need of pharmaceuticals, the best health outcomes that are reasonably achievable from pharmaceutical treatment and from within the amount of funding provided&rdquo;.</p>
<p>A funding application or proposal is considered ready for prioritisation when sufficient information is available to permit it to be reviewed against Pharmac's Factors for Consideration and to inform a comparison with other possible investment decisions.</p>
<p>There is no guarantee when or if a ranked medicine will be funded.&nbsp;&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/prioritisation/</a></p>",3,Options Compared,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Mar 2025', 'fs': 'Mar 2025', 'change': None}, 'Event_Description': {'s': 'The relative ranking of the pharmaceutical application has been completed.', 'fs': 'The relative ranking of the pharmaceutical application has been completed.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGE2AZ'}, 'Id': 'a0POZ00000TbtGE2AZ', 'Event_Date__c': '2025-03-18', 'Event_Description__c': 'The relative ranking of the pharmaceutical application has been completed.', 'Stage__c': 'Options Compared', 'Formatted_Date__c': 'Mar 2025', 'Status_History__c': 'a13OZ00000LGQdoYAH'}, 'change': None}]",Mar 2025,False,True
4,"<p>Pharmac is consulting on a proposal to either approve or decline the application.&nbsp;We seek the views of all people who have an interest in our proposals, or who may be affected by them, to obtain feedback on our proposed approaches.</p>
<p><a class=""external-link"" href=""https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/"" rel=""nofollow"">https://www.pharmac.govt.nz/medicines/how-medicines-are-funded/having-your-say/</a></p>",4,Under Consultation,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': '<p><a href=""https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/proposal-to-fund-silver-diamine-fluoride-for-hospital-and-paediatric-regional-dental-services"" target=""_blank"">Consultation notification</a></p>', 'fs': '<p><a href=""https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/proposal-to-fund-silver-diamine-fluoride-for-hospital-and-paediatric-regional-dental-services"" target=""_blank"">Consultation notification</a></p>', 'change': None}, 'Formatted_Date': {'s': 'Oct 2025', 'fs': 'Oct 2025', 'change': None}, 'Event_Description': {'s': 'Public consultation for this application is active.', 'fs': 'Public consultation for this application is active.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGF2AZ'}, 'Id': 'a0POZ00000TbtGF2AZ', 'Event_Date__c': '2025-10-16', 'Event_Description__c': 'Public consultation for this application is active.', 'Stage__c': 'Under Consultation', 'Links__c': '<p><a href=""https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/proposal-to-fund-silver-diamine-fluoride-for-hospital-and-paediatric-regional-dental-services"" target=""_blank"">Consultation notification</a></p>', 'Formatted_Date__c': 'Oct 2025', 'Status_History__c': 'a13OZ00000VtqViYAJ'}, 'change': None}]",Oct 2025,False,True
5,"<p>Following the consultation process, Pharmac staff considers the feedback and identifies any additional information required as part of a gap analysis.&nbsp; The proposal may require further clinical advice, research, and assessment.</p>",5,Reviewing Consultation Feedback,False,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': None, 'fs': None, 'change': None}, 'Formatted_Date': {'s': 'Nov 2025', 'fs': 'Nov 2025', 'change': None}, 'Event_Description': {'s': 'Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.', 'fs': 'Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGG2AZ'}, 'Id': 'a0POZ00000TbtGG2AZ', 'Event_Date__c': '2025-11-01', 'Event_Description__c': 'Public consultation for this application is now closed. Pharmac is reviewing consultation feedback.', 'Stage__c': 'Reviewing Consultation Feedback', 'Formatted_Date__c': 'Nov 2025', 'Status_History__c': 'a13OZ00000Vu1KkYAJ'}, 'change': None}]",Nov 2025,False,True
6,"<p>We refer to our decisions about whether and how particular pharmaceuticals are publicly-funded, as &ldquo;funding decisions&rdquo;.</p>
<p>We consider and assess all funding decisions using the&nbsp;<a class=""external-link"" href=""https://www.pharmac.govt.nz/about/operating-policies-and-procedures/#factorsfc"" rel=""nofollow"">Factors for Consideration</a>. When we do so, we carefully evaluate clinical and other evidence for the benefits and suitability of a proposal, and to identify and understand the people who will be affected by it.</p>
<p>While our main task is to allocate pharmaceutical funding, we consider the benefits and costs across the whole health system now and with a long-term focus, including the effects for hospitals and primary care, and consider direct costs to patients as well as to all health sector budgets.</p>
<p>Final funding decisions are made by the Pharmac Board or delegated to senior Pharmac staff as required by the Board.</p>
<p>&nbsp;</p>",6,Decision,True,"[{'Summary': {'s': None, 'fs': None, 'change': None}, 'Published_Recommendation': {'s': None, 'fs': None, 'change': None}, 'Published_Discussion': {'s': None, 'fs': None, 'change': None}, 'Published_Application': {'s': None, 'fs': None, 'change': None}, 'PTAC_Comments': {'s': None, 'fs': None, 'change': None}, 'Outcome': {'s': None, 'fs': None, 'change': None}, 'Links': {'s': '<p><a href=""https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-silver-diamine-fluoride-for-hospital-services-and-the-health-nz-community-oral-health-service"" target=""_blank"">Decision notification</a></p>', 'fs': '<p><a href=""https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-silver-diamine-fluoride-for-hospital-services-and-the-health-nz-community-oral-health-service"" target=""_blank"">Decision notification</a></p>', 'change': None}, 'Formatted_Date': {'s': 'Nov 2025', 'fs': 'Nov 2025', 'change': None}, 'Event_Description': {'s': 'The funding application has been approved.', 'fs': 'The funding application has been approved.', 'change': None}, 'e': {'attributes': {'type': 'Application_Event__c', 'url': '/services/data/v65.0/sobjects/Application_Event__c/a0POZ00000TbtGH2AZ'}, 'Id': 'a0POZ00000TbtGH2AZ', 'Event_Date__c': '2025-11-12', 'Event_Description__c': 'The funding application has been approved.', 'Stage__c': 'Decision', 'Links__c': '<p><a href=""https://www.pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-silver-diamine-fluoride-for-hospital-services-and-the-health-nz-community-oral-health-service"" target=""_blank"">Decision notification</a></p>', 'Formatted_Date__c': 'Nov 2025', 'Status_History__c': 'a13OZ00000VuA1LYAV'}, 'change': None}]",Nov 2025,False,True
